Management of renal cell carcinoma in von Hippel-Lindau disease

European Journal of Clinical Investigation

Volumn 29, Issue 1, 1999, Pages 68-75

  Hes, F J ^a,b   Slootweg, P J ^a   Van Vroonhoven, T J M V ^a   Hene R J ^a   Feldberg, M A M ^a   Zewald, R A ^b   Van Amstel, J K Ploos ^b   Hoppener J W M ^a   Pearson, P L ^c   Lips, C J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Clinical Genetics Center Utrecht   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Kidney neoplasms; Nephron sparing surgery; Pathology; Renal cell carcinoma; Von Hippel Lindau disease

Indexed keywords

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL EXAMINATION; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; NEPHRECTOMY; PRIORITY JOURNAL; TREATMENT OUTCOME; VON HIPPEL LINDAU DISEASE;

ADULT; AGE OF ONSET; CARCINOMA, RENAL CELL; CARRIER STATE; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HIPPEL-LINDAU DISEASE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; PEDIGREE; RETROSPECTIVE STUDIES;

EID: 0032967380     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00402.x     Document Type: Article

References (41)

1. 1 Neumann HPH, Wiestler OD. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet 1991;337:1052-4.
2. 2 Neumann HPH. Pheochromocytomas multiple endocrine neoplasia type 2 and von Hippel-Lindau disease. N EngI J Med 1994;330:1091-2.
3. 3 Maher ER, Iselius L, Yates JR, et al. Von Hippel-Lindau disease: a genetic study. J Med Genet 1991;28:443-7.
4. 4 Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260:1317-20.
5. 5 Brauch H, Kishida T, Glavac D, et al. von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Hum Genet 1995;95:551-6.
6. 6 Lamiell JM, Salazar FG, Hsia YE. von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine 1989;68:1-29.
7. 7 Choyke PL, Glenn GM, Walther MM, et al. The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients. AJR 1992;159:1229-34.
8. 8 Porter KA. Tumours of the kidneys and renal complications of extrarenal cancer. In: Symmers WStC, editor. Systemic pathology 3rd edn, Vol. 8. The kidneys. Edinburgh: Churchill Livingstone; 1992. pp. 569-620.
9. 9 Thoenes W, Storkel S, Rumpelt HJ. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 1986;181:125-43.
10. 10 Karsdorp N, Elderson A, Wittebol Post D, et al. Von Hippel-Lindau disease: new strategies in early detection and treatment. Am J Med 1994;97:158-68.
11. 11 Shinohara N, Nonomura K, Harabayashi T, Togashi M, Nagamori S, Koyanagi T. Nephron sparing surgery for renal cell carcinoma in von Hippel-Lindau disease. J Urol 1995;154:2016-9.
12. 12 Steinbach F, Novick AC, Zincke H, et al. Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol 1995;153:1812-6.
13. 13 Poston CD, Jaffe GS, Lubensky IA, et al. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications. J Urol 1995;153:22-6.
14. 14 Novick AC, Streem SB. Long-term followup after nephron sparing surgery for renal cell carcinoma in von Hippel-Lindau disease. J Urol 1992;147:1488-90.
15. 15 Lund GO, Fallon B, Cure's MA, Williams RD. Conservative surgical therapy of localized renal cell carcinoma in von Hippel-Lindau disease. Cancer 1994;74:2541-5.
16. 16 Walther MM, Choyke PL, Weiss G, et al. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma. J Urol 1995;153:913-6.
17. 17 Melmon KL, Rosen SW. Lindau's disease: Review of the literature and study of a large kindred. Am J Med 1964;36:595-617.
18. 18 Neumann HPH. Basic criteria for clinical diagnosis and genetic counselling in von Hippel-Lindau syndrome. Vasa 1987;16:220-6.
19. 19 Novick AC, Zincke H, Neves RJ, Topley HM. Surgical enucleation for renal cell carcinoma. J Urol 1986;135:235-8.
20. 20 Spiessl B, Beahrs OH, Hermanek P. UICC-TNM atlas, 3rd edn. Berlin: Springer; 1990. pp. 251-9.
21. 21 Gnarra JR, Tory K, Weng Y, et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nature Genet 1994;7:85-90.
22. 22 Maher ER, Yates JR, Harries R, et al. Clinical features and natural history of von Hippel-Lindau disease. Q J Med 1990;77:1151-63.
23. 23 Neumann HPH. Prognosis of von Hippel-Lindau syndrome. Vasa 1987;16:309-11.
24. 24 Levine E, Collins DL, Horton WA, Schimke RNCT. Screening of the abdomen in von Hippel-Lindau disease. AJR 1982;139:505-10.
25. 25 Horton WA, Wong V, Eldridge R. Von Hippel-Lindau disease: clinical and pathological manifestations in nine families with 50 affected members. Arch Intern Med 1976;136:769-77.
26. 26 Kovacs G. Molecular cytogenetics of renal cell tumors. Adv Cancer Res 1993;62:89-124.
27. 27 Kragel PJ, Walther MM, Pestaner JP, Filling Katz MR. Simple renal cysts, atypical renal cysts, and renal cell carcinoma in von Hippel-Lindau disease: a lectin and immunohistochemical study in six patients. Mod Pathol 1991;4:210-4.
28. 28 Solomon D, Schwartz A. Renal pathology in von Hippel-Lindau disease. Hum Pathol 1988;19:1072-9.
29. 29 La Vecchia C, Negri E, D'Avanzo B, Franceshi S. Smoking and renal cell carcinoma. Cancer Res 1990;50:5231-3.
30. 30 Yu MC, Mack TM, Hanisch R, Cicioni C, Henderson BE. Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. J Natl Cancer Inst 1986;77:351-6.
31. 31 Muscat JE, Hoffmann D, Wynder EL. The epidemiology of renal cell carcinoma. A second look. Cancer 1995;75:2552-7.
32. 32 Novick AC, Streem SB, Montie JE, Pontes JE, Siegel S, Goormastic M. Conservative Surgery for Renal Cell Carcinoma: a Single-center Experience with 100 Patients. J Urol 1989;141:835-9.
33. 33 Walther MM, Lubensky IA, Venzon D, Zbar B, Linehan WM. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J Urol 1995;154:2010-5.
34. 34 Ibrahim RE, Weinberg DS, Weidner N. Atypical cysts and carcinomas of the kidneys in the phacomatoses. A quantitative DNA study using static and flow cytometry. Cancer 1989;63:148-57.
35. 35 Persad RA, Probert JL, Sharma SD, Haq A, Doyle PT. Surgical management of the renal manifestations of von Hippel-Lindau disease: a review of a United Kingdom case series. Br J Urol 1997;80:392-6.
36. 36 Miller DL, Choyke PL, Walther MM, et al. von Hippel-Lindau disease: inadequacy of angiography for identification of renal cancers. Radiology 1991;179:833-6.
37. 37 Flechner SM. Current status of renal transplantation. Patient selection, results, and immunosuppression. Urol Clin N Am 1994;21:265-82.
38. 38 Sankari BR, Wyner LM, Streem SB. Living unrelated donor renal transplantation. Urol Clin North Am 1994;21:293-8.
39. 39 Penn I. The effect of immunosuppression on pre-existing cancers. Transplantation 1993;55:742-7.
40. 40 Goldfarb DA, Neumann HPH, Penn I, Novick AC. Results of renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease. Transplantation 1997;64:1726-9.
41. 41 Birnbaum BA, Bosniak MA, Megibow AJ, Lubat E, Gordon RB. Observations on the growth of renal neoplasms. Radiology 1990;176:695-701.